The US Multiple Myeloma Therapeutics Market size was valued at USD 3.8 Bn. in 2023 and the total US Multiple Myeloma Therapeutics revenue is expected to grow at a CAGR of 2.8 % from 2024 to 2030, reaching nearly USD 4.61 Bn. in 2030. US Multiple Myeloma Therapeutics Market Overview Stellar Market Research, anUS Multiple Myeloma Therapeutics business research firm has published a...